![June Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
June Lee
Direktör/Styrelseledamot på
ELEDON PHARMACEUTICALS, INC.
Förmögenhet: - $ per 2026-08-31
Profil
June H.
Lee is the founder of Alumis, Inc., founded in 2021, serving as President & Chief Executive Officer in 2021.
Current jobs include Chairman at University of California Drug Discovery Consortium; Independent Director at Abivax SA since 2023; Director at Council of Korean Americans since 2017; Director at Breeze Bio, Inc.; Independent Director at Eledon Pharmaceuticals, Inc. since 2020; Independent Director at Tenaya Therapeutics, Inc. since 2021; and Director at NKGen Biotech Korea Co., Ltd. starting in 2025.
Former jobs include Independent Director at CinCor Pharma, Inc. from 2022 to 2023; Director-Translational Research & Professor at UCSF School of Medicine from 2011 to 2017; Chief Development Officer & Executive VP at MyoKardia, Inc. from 2019 to 2020; Head-Clinical Development at Genentech, Inc. from 2006 to 2011; and Venture Partner at 5AM Venture Management LLC from 2022 to 2024.
Education includes a doctorate from UC Davis School of Medicine conferred in 1991 and an undergraduate degree from The Johns Hopkins University conferred in 1988.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-31 | 0 ( -.--% ) | - $ | 2026-08-31 | |
| 2026-05-28 | 0 ( -.--% ) | - $ | 2026-08-31 | |
ABIVAX SA -.--% | 2026-02-28 | 0 ( -.--% ) | - $ | 2026-08-31 |
Aktiva positioner av June Lee
| Företag | Position | Start |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2020-12-09 |
| TENAYA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-11-19 |
| ABIVAX | Direktör/Styrelseledamot | 2023-07-11 |
| NKGEN BIOTECH KOREA CO., LTD. | Direktör/Styrelseledamot | 2025-11-21 |
Council of Korean Americans | Direktör/Styrelseledamot | - |
GenEdit, Inc.
 GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Direktör/Styrelseledamot | - |
University of California Drug Discovery Consortium | Ordförande | - |
Tidigare kända positioner av June Lee
| Företag | Position | Slut |
|---|---|---|
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Privat kapitalinvesterare | 2024-11-30 |
| CINCOR PHARMA, INC. | Direktör/Styrelseledamot | 2023-02-24 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
June Lees utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
87
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
UC Davis School of Medicine
 UC Davis School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
UCSF School of Medicine
 UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Council of Korean Americans | |
NKMAX Co., Ltd. (South korea)
 NKMAX Co., Ltd. (South korea) BiotechnologyHealth Technology Manufactures biological products | Health Technology |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
University of California Drug Discovery Consortium |
